🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Estimated number of participants: 342 participants with COVID-19 Design: Ph...
Status
Completed
Location
Santa Casa de Misericordia de Campos
Start Date
2021-04-23
Trial ID
NCT04668235
Treatments Being Tested
Azvudine,(FNC)， new nuclear nucleoside reverse transcriptase inhibitors, FN...
Status
Unknown
Location
Beijing YouAn Hospital, Capital Medical University
Start Date
2020-04-01
Trial ID
NCT04303598
Treatments Being Tested
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Heping Hospital Affliliated to Changzhi Medical College
Start Date
2021-12-20
Trial ID
NCT07002255
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Phase I Clinical Trial Research Center of Dongguan Kanghua Hospital
Start Date
2022-02-21
Trial ID
NCT07001501
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Tianjin People's Hospital
Start Date
2022-07-06
Trial ID
NCT07002242
Treatments Being Tested
Phase III, single-center with co-participating units, randomized, double-bl...
Status
Completed
Location
Hospital Moacyr Gomes de Azevedo
Start Date
2022-01-15
Trial ID
NCT05033145
Treatments Being Tested
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Tianjin People's Hospital
Start Date
2021-12-09
Trial ID
NCT07002229
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Beijing Jishuitan Hospital
Start Date
2022-03-14
Trial ID
NCT07002268
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Phase I Clinical Trial Research Center of Dongguan Kanghua Hospital
Start Date
2022-02-21
Trial ID
NCT07001488
To evaluate the efficacy and safety of azvudine in treatment of COVID-19...
Status
Unknown
Location
Multiple Locations
Start Date
2020-06-12
Trial ID
NCT04425772
Treatments Being Tested